½ÉÀåÇ÷°ü¿µ»ó¿¬±¸È¸ Echo Seoul & Cardiac Imaging 2021 (1ÀÏÂ÷) : 2021-09-11±³À°ÀÏÀÚ : 2021-09-11
±³À°Àå¼Ò : ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® ±×·£µåº¼·ë
±³À°ÁÖÁ¦ :
Echo Seoul & Cardiac Imaging 2021 (1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀåÇ÷°ü¿µ»ó¿¬±¸È¸
´ã´çÀÚ : ¿î¿µ»ç¹«±¹
¿¬¶ôó : 02-6002-1391
À̸ÞÀÏ :
echo@echoseoul.org ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í °³¿øÀÇ, Àü¹®ÀÇ : 10¸¸¿ø / ÀüÀÓÀÇ, ±ºÀÇ°ü, °øÁߺ¸°ÇÀÇ : 7¸¸¿ø / Àü°øÀÇ ¹× ±âŸ : 4¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09-11 ±×·£µåº¼·ë 08:30~08:35 Opening remark ÇÏÁ¾¿ø(¿¬¼¼ÀÇ´ë)
Åä·Ð 09-11 ±×·£µåº¼·ë 08:35~08:45 Cases for discussion ±è´ë¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 08:45~09:00 Echo: Strength and weakness for diagnosis and follow-up À±¿¬ÀÌ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 09:00~09:15 CMR: Strength and weakness for diagnosis and follow-up ±è¼º¸ñ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 09:15~09:30 Nuclear Imaging: Strength and weakness for diagnosis and follow-up ÃÖÁØ¿µ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 09:30~09:45 Genetics and biomakers beyond imaging ÃÖÀÇ¿µ(¿¬¼¼ÀÇ´ë)
Åä·Ð 09-11 ±×·£µåº¼·ë 09:45~10:00 Panel Discussion ¹Úöȯ/±è¹ÌÁ¤/À̽¾Æ(¿¬¼¼ÀÇ´ë/°¡Å縯ÀÇ´ë/¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 10:00~10:15 Are you really following the guidelines in clinical practice? Sherif F. Nagueh(Houston Methodist)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 10:15~10:30 How detailed should the left atrium be examined? Jae K. Oh(Mayo Clinic)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 10:30~10:45 When diastolic stress test is particularly useful? ÇÏÁ¾¿ø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 10:45~11:00 GLS, myocardial work imaging and diastolic function Otto A. Smiseth(Oslo Univ. Hosp.)
Åä·Ð 09-11 ±×·£µåº¼·ë 11:00~11:15 Panel Discussion ±è¼ºÈ¯/±èÇüÀ±/Á¤ÀÎÇö(°í·ÁÀÇ´ë/Àü³²ÀÇ´ë/¿¬¼¼ÀÇ´ë¿ëÀÎ)
ÈÞ½Ä 09-11 ±×·£µåº¼·ë 11:15~11:35 break ()
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 11:35~11:50 Diastolic function in patients with atrial fibrillation ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 11:50~12:05 Diastolic function in patients with mitral valve disease ¹Ú¼ºÁö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 12:05~12:20 Diastolic function in patients with hypertrophic cardiomyopathy ±èÇü°ü(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 12:20~12:35 Diastolic function in patients with fraility and sarcopenia Kazuhiro Yamamoto(Tottori Univ.)
Åä·Ð 09-11 ±×·£µåº¼·ë 12:35~12:50 Panel Discussion º¯¿µ¼·/±è¹Ì³ª/±è¼º¾Ö(ÀÎÁ¦ÀÇ´ë/°í·ÁÀÇ´ë/ÇѸ²ÀÇ´ë)
½Ä»ç 09-11 ±×·£µåº¼·ë 12:50~13:50 Á¡½É½Ä»ç ()
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 13:50~14:10 Special Lecture ¼Õ´ë¿ø(¼¿ï¿øÇÏÆ®³»°ú)
Åä·Ð 09-11 ±×·£µåº¼·ë 14:10~14:20 Cases for Discussion ¼Áö¿ø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 14:20~14:35 How to define MR with uncertain etiolgy or ambiguous severity Á¤Çؾï(Ä«Å縯ÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 14:35~14:50 Natural history and outcomes of MR using large data sets À̽ÂÇ¥(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 14:50~15:05 Echo for clinical trials: MR and chambers °´öÇö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 15:05~15:20 When to intervene? LV systolic dimension, LVEF, vs. LV strain Á¶±¸¿µ(¼¿ïÀÇ´ë)
Åä·Ð 09-11 ±×·£µåº¼·ë 15:20~15:35 Panel Discussion ¼ÕÀϼ®/³ªÁø¿À/Á¤ÇöÁÖ(°æÈñÀÇ´ë/°í·ÁÀÇ´ë/ÇѾçÀÇ´ë)
ÈÞ½Ä 09-11 ±×·£µåº¼·ë 15:35~15:50 break ()
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 15:50~16:05 Properties, thrombogenecity, and durability of prosthetic valves ÀÌ»è(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 16:05~16:20 2D/3D echo for patients with elevated prosthetic valve pressure gradient ÀÌ»ç¹Î(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 16:20~16:35 Cardiac CT for patients with elevated prosthetic valve pressure gradient ¼¿µÁÖ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 16:35~16:50 Nuclear imaging for patients with elevated prosthetic valve pressure gradient ÆØÁøö(¼¿ïÀÇ´ë)
Åä·Ð 09-11 ±×·£µåº¼·ë 16:50~17:05 Panel Discussion Ȳ¼ºÈ£/½Å¼ºÈñ/³²Á¾È£(°í·ÁÀÇ´ë/ÀÎÇÏÀÇ´ë/¿µ³²ÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 17:05~17:15 Case 1: DCM with moderate AR vs. severe AR with LVD Á¶µ¿Çõ(¿¬¼¼ÀÇ´ë¿øÁÖ)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 17:15~17:25 Case 2: DCM with moderate AS vs. severe AS with LVD ȲÀÎâ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 17:25~17:40 Myocardial remodeling and reverse remodeling in AV disease ±è´ëÈñ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 17:40~17:55 CT/CMR for differential diagnosis and predicting reverse remodeling È«À¯Áø(¿¬¼¼ÀÇ´ë)
Åä·Ð 09-11 ±×·£µåº¼·ë 17:55~18:10 Panel Discussion ÃÖÀçÇõ/À̼ö¿¬/ÀÌ»óÀç(ÇѸ²ÀÇ´ë/¼¼Á¾º´¿ø/¿ø±¤´ëÀÇ´ë)